ARCHIVES

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

New HIP Analysis Supports Mammography Screening Ages 40-49

September 23, 1988

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991